Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries
The DOI matches its Crossref record, with a small difference in title or year; 39 of the 45 references it cites were found in a registry or an index.
Abstract
Background The large observed variability in hemophilia prevalence prevents robust estimation of burden of disease. Objective To estimate the prevalence and prevalence at birth of hemophilia and the associated life expectancy disadvantage. Design Random-effects meta-analysis of registry data. Setting Australia, Canada, France, Italy, New Zealand, and the United Kingdom. Participants Male patients with hemophilia A or B. Measurements Prevalence of hemophilia as a proportion of cases to the male population, prevalence of hemophilia at birth as a proportion of cases to live male births by year of birth, life expectancy disadvantage as a 1 - ratio of prevalence to prevalence at birth, and expected number of patients worldwide based on prevalence in high-income countries and prevalence at birth. Results Prevalence (per 100 000 males) is 17.1 cases for all severities of hemophilia A, 6.0 cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth (per 100 000 males) is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, 5.0 cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage for high-income countries is 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The expected number of patients with hemophilia worldwide is 1 125 000, of whom 418 000 should have severe hemo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HA and hemophilia B (HB) are X-linked monogenic disorders resulting from decreased/absent function of coagulation FVIII or FIX.165,166”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [165]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Random-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A
Lakich, D., Kazazian, H. H., Antonarakis, S. E., & Gitschier, J. (1993) · Nature Genetics · doi:10.1038/ng1193-236 · Cited by 788
Darby, S. C., Kan, S. W., Spooner, R. J., Giangrande, P. L. F., Hill, F. G. H., Hay, C. R. M., Lee, C. A., Ludlam, C. A., & Williams, M. (2007) · Blood · doi:10.1182/blood-2006-10-050435 · Cited by 511
Gringeri, A., Mantovani, L. G., Scalone, L., Mannucci, P. M., & the COCIS Study Group (2003) · Blood · doi:10.1182/blood-2003-03-0941 · Cited by 372
Occurrence of hemophilia in the United States
Soucie, J. M., Evatt, B., Jackson, D., & the Hemophilia Surveillance System Project Investigators (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199812)59:4<288::aid-ajh4>3.0.co;2-i · Cited by 346
A study of variations in the reported haemophilia A prevalence around the world
STONEBRAKER, J. S., BOLTON‐MAGGS, P. H. B., MICHAEL SOUCIE, J., WALKER, I., & BROOKER, M. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02127.x · Cited by 296
Self-citation450 million years of hemostasis
Davidson, C. J., Tuddenham, E. G., & McVey, J. H. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00334.x · Cited by 169
Mortality and causes of death in Italian persons with haemophilia, 1990–2007
TAGLIAFERRI, A., RIVOLTA, G. F., IORIO, A., OLIOVECCHIO, E., MANCUSO, M. E., MORFINI, M., ROCINO, A., MAZZUCCONI, M. G., FRANCHINI, M., & ON BEHALF OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTERS (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02188.x · Cited by 168
Self-citation
Cited by
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
How are systematic reviews of prevalence conducted? A methodological study
on behalf of the Prevalence Estimates Reviews – Systematic Review Methodology Group (PERSyst), Borges Migliavaca, C., Stein, C., Colpani, V., Barker, T. H., Munn, Z., & Falavigna, M. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-00975-3 · Cited by 359
Hemophilia therapy: the future has begun
Mannucci, P. M. (2020) · Haematologica · doi:10.3324/haematol.2019.232132 · Cited by 223
The World Federation of Hemophilia Annual Global Survey 1999‐2018
Stonebraker, J. S., Bolton‐Maggs, P. H. B., Brooker, M., Evatt, B. L., Iorio, A., Makris, M., O’Mahony, B., Skinner, M. W., Coffin, D., Pierce, G. F., et al. (2020) · Haemophilia · doi:10.1111/hae.14012 · Cited by 140
Self-citationKlamroth, R., Hayes, G., Andreeva, T., Gregg, K., Suzuki, T., Mitha, I. H., Hardesty, B., Shima, M., Pollock, T., Slev, P., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2021.287 · Cited by 118
Metadata
- Authors
- Iorio, A., Stonebraker, J. S., Chambost, H., Makris, M., Coffin, D., Herr, C., Germini, F., & for the Data and Demographics Committee of the World Federation of Hemophilia*
- Affiliations
- McMaster University (CA)
- North Carolina State University (US)
- La Timone Hospital of Assistance Publique – Hôpitaux de Marseille, Aix-Marseille University, Institut National de la Santé et de la Recherche Médicale, and Institut National de la Recherche Agronomique, Marseille, France (H.C.)
- University of Sheffield (GB)
- World Federation of Hemophilia (CA)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2019-10-15
- Volume
- 171
- Issue
- 8
- Pages
- 540-546
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2972722566
- Cited by
- 462
- References
- 45
- Citations by year
- 2026: 57 · 2025: 76 · 2024: 80 · 2023: 71 · 2022: 75 · 2021: 64 · 2020: 34 · 2019: 4
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Annals of Internal Medicine
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Keywords
- hemophilia, hemophilia A, hemophilia B, prevalence, life expectancy, disease burden, severe hemophilia, years of life lost
- MeSH terms
- Australia, Canada, France, United Kingdom, Hemophilia A, Humans, Infant, Newborn, Italy, Life Expectancy, Male, New Zealand, Registries, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. https://app.cochat.ai/papers/10.7326/m19-1208
- The paper
- Iorio, A., Stonebraker, J. S., Chambost, H., Makris, M., Coffin, D., Herr, C., Germini, F., & for the Data and Demographics Committee of the World Federation of Hemophilia*. (2019). Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries. Annals of Internal Medicine. https://doi.org/10.7326/m19-1208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.